Antabio

Infectious Disease Therapeutics · Health Care
$31.4MTotal raised
Data updated Nov 20, 2026Money ledger: 3 records from 3 sourcesFiled 1Announced 2Full reportReport a mistake

Facts

as of Nov 20, 2026

Antabio develops novel antibiotics against drug-resistant Gram-negative bacteria and antimicrobial resistance.

Legal name
ANTABIO Limitedactive
Headquarters
Labège, France
Founded
2009
Employees
10–19French register · Dec 2023
Official records
Wikidata Q112112502

These are the key facts about Antabio on Alion as of Nov 20, 2026. Antabio is headquartered in Labège, France. It was founded in 2009. It has raised $31.4M in 2 funding rounds. The latest round is Series B of $27M, announced in 2023.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Antabio has $31.4M paid in by investors, lenders and donors.

$31.4MPaid in
Money innewest first
Equity raised
Dec 2023 · Series B
$27MPaid
Grant
Feb 2023 · Grant
$2.7MPaid
Equity raised
Jan 2020 · Venture round
$4.4MPaid
Money by yearUSD, rounds and grants
2023$29.7M2 records
2020$4.4M1 record
Every row links its own source. A flow two sources state counts once; a figure a source does not state reads "not stated".

People

10–19EmployeesFrench register · Dec 2023

Products

Products →

Antabio has 3 clinical trials on record, 0 under way.

Clinical trials
Evaluation of the Concentration of ANT3310 and Meropenem in the Lung in Healthy Adult Participants
phase 1 · completed · 26 participants · Pharmacokinetics Study on Healthy Volunteers Adults
Apr 2025
Assessment of the Pharmacokinetics and Safety of ANT3310 Combined With Meropenem in Renally Impaired Subjects
phase 1 · completed · 41 participants · Renal Impairment
Jul 2024
FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects
phase 1 · completed · 72 participants · Healthy Volunteers
Apr 2023
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.

Antabio: EUR 0–10,000 of EU lobbying in 2025.

Legal entity active
ANTABIO Limited
Yes
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
EU lobbying, declared
2025
EUR 0–10,000
Patents
8
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Sources: the outlets named on each headline, each story once

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Labège FranceHeadquarters0
Source: office addresses in postings and company registers